mafosfamide has been researched along with Leukemia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (33.33) | 18.7374 |
| 1990's | 12 (57.14) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, SL; Blaney, SM; D'Argenio, DZ; Jacob, E; Scorsone, K | 1 |
| Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Douay, L; Giarratana, MC; Gorin, NC | 1 |
| Bouchet, S; Capizzi, RL; Conlon, J; Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Bezobrazova, LV; Korneva, EN; Moskaleva, EIu; Semenova, OI; Tarakanov, MP; Telegin, LIu | 1 |
| Hassan, HT; Maurer, HR | 1 |
| Douay, L; Fouillard, L; Isnard, F; Jouet, JP; Labopin, M; Laporte, JP; Lesage, S; Lopez, M; Noel-Walter, MP; Stachowiak, J | 1 |
| Binet, C; Brémond, JL; Chenault, S; Colombat, P; Desbois, I; Domenech, J; Gihana, E; Lamagnère, JP; Linassier, C | 1 |
| Douay, L; Gorin, NC; Isnard, F; Laporte, JP; Lopez, M; Najman, A; Perot, C; Stachowiak, J; Taillemite, JL; van den Akker, J | 1 |
| Gorin, NC | 1 |
| Bialleck, H; Fauth, F; Hoelzer, D; Martin, H; Mihanovic, B; Sonnhoff, S; Wiesneth, M | 1 |
| Accorsi, P; Angelini, A; Angrilli, F; Berardi, A; D'Antonio, D; Di Bartolomeo, G; Di Bartolomeo, P; Dragani, A; Iacone, A; Quaglietta, AM | 1 |
| Balis, FM; Blaney, SM; Poplack, DG | 1 |
| Mangoni, L; Rizzoli, V | 1 |
| Centurioni, R; Leoni, P; Masia, C; Montillo, M; Olivieri, A | 1 |
| Manna, A; Pazzaglia, C; Porcellini, A; Rossi, MT; Sparaventi, G | 1 |
| Hilgard, P; Peukert, M; Sindermann, H | 1 |
| Alessandrino, EP; Angrilli, F; Carella, AM; Coleselli, P; Falda, M; Mangoni, L; Miniero, A; Mozzana, R; Novarino, A; Rizzoli, V | 1 |
| Myers, DE; Vallera, DA | 1 |
| Aglietta, M; Alessandrino, EP; Carella, AM; Coleselli, P; Degliantoni, G; Mangoni, L; Mozzana, R; Porcellini, A; Resegotti, L; Torlontano, G | 1 |
| Hervé, P; Tamayo, E | 1 |
4 review(s) available for mafosfamide and Leukemia
| Article | Year |
|---|---|
Agar capillary clonogenic microassays for cellular immunocytotoxic activities in human leukaemia and lymphoma.
Topics: Agar; Cyclophosphamide; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Humans; Immunotherapy, Adoptive; Interferons; Interleukins; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia; Lymphoma; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1993 |
The potential role of amifostine (Ethyol) in haematological malignancies.
Topics: Acute Disease; Adult; Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1996 |
Bone marrow purging with mafosfamide--a critical survey.
Topics: Animals; Bone Marrow; Bone Marrow Transplantation; Chemical Phenomena; Chemistry; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Humans; Hydrolysis; Leukemia; Mice | 1989 |
Immunotoxins containing ricin.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Cross-Linking Reagents; Cyclophosphamide; Drug Evaluation; Drug Synergism; Galactose; Humans; Immunotoxins; Leukemia; Melanoma; Neoplasms; Receptors, Mitogen; Ricin; Yttrium | 1988 |
4 trial(s) available for mafosfamide and Leukemia
| Article | Year |
|---|---|
One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Graft Survival; Humans; Leukemia; Male; Middle Aged; Multivariate Analysis; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1994 |
Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Amifostine; Bone Marrow; Bone Marrow Purging; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Leukemia; Male; Middle Aged; Stem Cells; Transplantation, Autologous | 2000 |
Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cell Separation; Centrifugation, Density Gradient; Cryoprotective Agents; Cyclophosphamide; Dimethyl Sulfoxide; Ficoll; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Neoplastic Stem Cells; Transplantation, Autologous | 1991 |
Purging procedures for acute leukaemias in autologous BMT.
Topics: Adult; Bone Marrow Transplantation; Cell Separation; Clinical Trials as Topic; Cyclophosphamide; Humans; In Vitro Techniques; Leukemia; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1989 |
13 other study(ies) available for mafosfamide and Leukemia
| Article | Year |
|---|---|
Synergy of karenitecin and mafosfamide in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Child; Cyclophosphamide; Drug Synergism; Humans; Leukemia; Medulloblastoma; Neuroblastoma | 2008 |
Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1995 |
Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Cell Differentiation; Colony-Forming Units Assay; Cyclophosphamide; Female; Hematopoietic Stem Cells; Humans; Leukemia; Male; Middle Aged; Plasma | 1995 |
Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Cell Death; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1995 |
[The structure of the leukocyte DNA in leukemia patients during chemotherapy].
Topics: Antineoplastic Agents; Cyclophosphamide; DNA Damage; DNA, Neoplasm; Female; Humans; Leukemia; Leukocytes; Lymphoma, T-Cell; Male; Nucleic Acid Denaturation; Tumor Cells, Cultured | 1993 |
Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Purging; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1993 |
Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with mafosfamide.
Topics: Antineoplastic Agents; Bone Marrow Purging; Chromosome Aberrations; Cyclophosphamide; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Transplantation, Autologous; Treatment Outcome | 1993 |
Pharmacologic approaches to the treatment of meningeal malignancy.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa | 1991 |
Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1990 |
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line].
Topics: Bleomycin; Bone Marrow; Cell Line; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Leukemia; Tumor Stem Cell Assay | 1986 |
Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization.
Topics: Antineoplastic Agents; Bone Marrow; Cell Line; Colony-Forming Units Assay; Cyclophosphamide; Dye Dilution Technique; Humans; Leukemia; Light; Pyrimidinones; Radiation-Sensitizing Agents; Tumor Stem Cell Assay | 1989 |
Autologous bone marrow transplantation in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Child; Cyclophosphamide; Evaluation Studies as Topic; Humans; Leukemia; Preoperative Care; Transplantation, Autologous | 1987 |
Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Humans; Leukemia; Lymphocyte Activation; Time Factors; Transplantation, Autologous | 1988 |